CD79A and nasopharyngeal carcinoma: Another study, which only included patients with undetectable pre-treatment EBV DNA levels in order to reduce the inference of EBV DNA levels on prognosis, showed that both EA-IgA and VCA-IgA did not have prognostic value for patients with NPC [83].